These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 667371)

  • 1. [Rubidazone (22 050 RP): clinical study. Phase II trial in solid tumors and lymphomas (author's transl)].
    Chauvergne J; Cappelaere P; Carton M; Gary-Bobo J; Klein T
    Bull Cancer; 1978; 65(1):19-24. PubMed ID: 667371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of rubidazone in solid tumors and malignant lymphomas.
    Skovsgaard T; Hansen HH; Mouridsen HT; Nissen NI; Pedersen-Bjergaard J
    Cancer Treat Rep; 1978 Jul; 62(7):1053-8. PubMed ID: 356967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticancerous chemotherapy trial with duborimycin. Analysis of 151 cases].
    Chauvergne J; Carton M; Berlie J; Brulé G; Clavel B; Gary-Bobo J; Guerrin J; Klein T; Pommatau E
    Bull Cancer; 1976; 63(1):41-58. PubMed ID: 990509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
    Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
    Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
    Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER
    Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.
    Zidar BL; Benjamin RS; Frank J; Lane M; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):71-4. PubMed ID: 6837508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
    Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
    Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survey of anthracyclines derivatives in haematology (author's transl)].
    Jacquillat C; Weil M; Auclerc MF; Maral J; Schaison G; Boiron M; Bernard J
    Nouv Presse Med; 1978 Jun; 7(23):2061-6. PubMed ID: 673774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II clinical evaluation of 4'-epi-doxorubicin.
    Hurteloup P; Cappelaere P; Armand JP; Mathé G
    Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Rose PG; Blessing JA; Lele S; Abulafia O
    Gynecol Oncol; 2006 Aug; 102(2):210-3. PubMed ID: 16478630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
    Bastholt L; Dalmark M
    Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
    Kovach JS; Ames MM; Sternad ML; O'Connell MJ
    Cancer Res; 1979 Mar; 39(3):823-8. PubMed ID: 427770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline].
    Korman DB; Mikaélian SG; Boronovskaia LE; Maslova IA
    Vopr Onkol; 2004; 50(2):202-7. PubMed ID: 15176224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
    Jelić S; Tomasević Z; Kreacić M; Kovcin V; Radosavljević D; Vlajić M
    Bull Cancer; 1996 Dec; 83(12):1002-7. PubMed ID: 9116363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The therapeutic efficacy and toxicity of the liposomal form of daunorubicin (Daunoxome) in lymphosarcoma patients].
    Medvedev PV; Nikitin EA; Pivnik AV
    Ter Arkh; 2000; 72(7):38-42. PubMed ID: 10983319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.